Pharmavoice Podcasts

Date: 4/23/2008Length: 00:12:14Size: 5.60MBThought Leaders: John Lagus, VP of Business and Corporate Development, IDISThis final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.Play PodcastFree Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"Download RelatedWhite PaperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.